BAM Capital as of June 30, 2011
Portfolio Holdings for BAM Capital
BAM Capital holds 27 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 37.2 | $37M | 675k | 55.10 | |
| Vivus | 7.4 | $7.4M | 906k | 8.14 | |
| Delcath Systems | 6.5 | $6.5M | 1.3M | 5.16 | |
| Elan Corporation | 6.4 | $6.4M | 562k | 11.37 | |
| Keryx Biopharmaceuticals | 5.6 | $5.6M | 1.2M | 4.73 | |
| Targacept | 5.5 | $5.5M | 259k | 21.05 | |
| Amarin Corporation | 4.7 | $4.7M | 322k | 14.47 | |
| Gen-Probe Incorporated | 4.2 | $4.2M | 61k | 69.15 | |
| Biogen Idec (BIIB) | 3.6 | $3.6M | 33k | 106.91 | |
| VirnetX Holding Corporation | 3.2 | $3.2M | 112k | 28.94 | |
| Spdr S&p 500 Etf (SPY) | 2.6 | $2.6M | 20k | 131.95 | |
| Pharmasset | 2.5 | $2.5M | 22k | 112.18 | |
| Best Buy (BBY) | 1.5 | $1.5M | 46k | 31.42 | |
| Ariad Pharmaceuticals | 1.2 | $1.2M | 110k | 11.33 | |
| AVEO Pharmaceuticals | 1.1 | $1.1M | 54k | 21.00 | |
| XenoPort | 1.1 | $1.1M | 157k | 7.12 | |
| Acorda Therapeutics | 1.1 | $1.1M | 33k | 32.30 | |
| Dendreon Corporation | 0.9 | $925k | 23k | 39.57 | |
| Forest Laboratories | 0.9 | $858k | 22k | 39.36 | |
| Human Genome Sciences | 0.7 | $676k | 28k | 24.58 | |
| BioMimetic Therapeutics | 0.7 | $686k | 134k | 5.12 | |
| Orexigen Therapeutics | 0.5 | $530k | 333k | 1.59 | |
| Onyx Pharmaceuticals | 0.5 | $536k | 15k | 35.00 | |
| Eli Lilly & Co. (LLY) | 0.3 | $289k | 7.7k | 37.53 | |
| Genvec | 0.1 | $125k | 39k | 3.24 | |
| Raptor Pharmaceutical | 0.1 | $77k | 13k | 6.16 | |
| GTx | 0.1 | $59k | 12k | 4.76 |
